[go: up one dir, main page]

ES8106834A1 - Antibody serum - Google Patents

Antibody serum

Info

Publication number
ES8106834A1
ES8106834A1 ES495177A ES495177A ES8106834A1 ES 8106834 A1 ES8106834 A1 ES 8106834A1 ES 495177 A ES495177 A ES 495177A ES 495177 A ES495177 A ES 495177A ES 8106834 A1 ES8106834 A1 ES 8106834A1
Authority
ES
Spain
Prior art keywords
igg
agglutination
serum
cells
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES495177A
Other languages
Spanish (es)
Other versions
ES495177A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gamma Biologicals Inc
Original Assignee
Gamma Biologicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gamma Biologicals Inc filed Critical Gamma Biologicals Inc
Publication of ES495177A0 publication Critical patent/ES495177A0/en
Publication of ES8106834A1 publication Critical patent/ES8106834A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Blood grouping serum containing antibodies specific to human blood antigens and capable of direct agglutination of red blood cells without enhancing the spontaneous agglutination of immunoglobulin- coated cells, are produced by treating whole serum or a fraction containing IgG antibodies, separating IgM and IgG, reducing and thereby breaking disulfide bonds in the IgG, fixing the reduced IgG to prevent re-oxidation, and recombining with IgG.
ES495177A 1979-12-26 1980-09-19 Antibody serum Expired ES8106834A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10749979A 1979-12-26 1979-12-26

Publications (2)

Publication Number Publication Date
ES495177A0 ES495177A0 (en) 1981-09-01
ES8106834A1 true ES8106834A1 (en) 1981-09-01

Family

ID=22316939

Family Applications (1)

Application Number Title Priority Date Filing Date
ES495177A Expired ES8106834A1 (en) 1979-12-26 1980-09-19 Antibody serum

Country Status (7)

Country Link
JP (1) JPS5694267A (en)
AU (1) AU6071780A (en)
DE (1) DE3028977A1 (en)
ES (1) ES8106834A1 (en)
GB (1) GB2066259B (en)
IT (1) IT8049473A0 (en)
NZ (1) NZ194363A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61213673A (en) * 1985-03-19 1986-09-22 Morinaga Milk Ind Co Ltd Production of reagent for immunological measurement
CA2008213A1 (en) * 1989-02-21 1990-08-21 David A. Hilborn Method of fragmenting certain monoclonal antibodies
GB8919761D0 (en) * 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
EP1465720A4 (en) * 2001-12-19 2010-05-12 Biogen Idec Inc Methods for detecting half-antibodies using chip-based gel electrophoresis
WO2005052567A1 (en) * 2003-11-24 2005-06-09 Biogen Idec Ma Inc. Methods for detecting half-antibodies using chip-based gel electrophoresis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5417721B2 (en) * 1974-03-08 1979-07-02
ZA804197B (en) * 1979-07-13 1982-02-24 Ortho Diagnostics Anti-d test and reagent

Also Published As

Publication number Publication date
IT8049473A0 (en) 1980-08-12
ES495177A0 (en) 1981-09-01
DE3028977A1 (en) 1981-07-02
GB2066259A (en) 1981-07-08
NZ194363A (en) 1982-12-21
GB2066259B (en) 1983-05-25
JPS5694267A (en) 1981-07-30
AU6071780A (en) 1981-07-02

Similar Documents

Publication Publication Date Title
DE3172465D1 (en) Method for the detection of fecal hemoglobin
SE8105827L (en) IMMUNO ANALYSIS PRODUCTS AND METHODS
IL76142A0 (en) Monoclonal antibody specific to human carcinoma tumorassociated antigen,hybrid cell lines producing the same and methods for the use thereof
DE3060928D1 (en) Method of magnetic separation of cells and the like, and microspheres for use therein
AU7307881A (en) Determination of antigens with monoclonal antibodies
DE3584035D1 (en) DETECTION OF HUMAN CYTOMEGALOVIRUS-SPECIFIC IGM.
EP0387286A4 (en) Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
DK98187A (en) MONOCLONAL ANTIBODIES AND ANTIGEN FOR HUMAN NON-SMALL CELL LUNGCARCINOMA AND CERTAIN OTHER TYPES OF HUMAN CARCINOMA
AU7345487A (en) Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen
ES8505406A1 (en) PROCEDURE FOR OBTAINING AND ISOLATING HYBRIDOMES, ANTIBODY SECRETORS, PROCEDURE FOR OBTAINING ANTIBODIES AND METHOD FOR OBTAINING POLYPEPTIDES
ES520012A0 (en) AGGLUTINATION PROCEDURE WITH LATEX FOR THE DETECTION OR DETERMINATION OF A PARTICIPANT IN AN IMMUNOLOGICAL REACTION.
ES8106834A1 (en) Antibody serum
AU2493184A (en) Specific cea-family antigens, antibodies specific thereto and their methods of use
IL61641A0 (en) Immunological detection of human cancer cells and antigens and antibodies for use therein
ES8602253A1 (en) Monoclonal immunoglobulin M antibodies and method of preparation.
AU2911289A (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
ES478806A1 (en) Erythrocytes sensitized with a single immunoglobulin or complement component.
EP0248147A3 (en) Method of determining the presence of cancer cells
AU582129B2 (en) Circulating antigens of dirofilaria immitis,monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
SASAHIRA SERODIAGNOSIS OF SYPHILIS BY FLUORESCENT TREPONEMAL ANTIBODY TEST (FTA TEST). 2. ON THE TRANSITION OF ANTIBODIES OF 7 S GAMMA TYPE IN THE SYPHILITIC SERA IN EACH STAGE AND THE SPECIFICITY OF FTA TEST
SU1356287A1 (en) METHOD OF OBTAINING IMMUNE SERIES
Cummings et al. Purification of human Fd'with anti-light chain antisera
HRP940830B1 (en) Hybrid cell line for producing monoclonal antibody to a human t cell antigen, antibody, and methods
PL245361A1 (en) Method of obtaining antibodies specific for antigens isolated from human serum,in particular for the antigen hbs.